Wednesday, August 22, 2018
9:00 – 11:00 am
Crystal Ballroom G1
Convention Level
9:00 – 10:00 am
Evidence Based Medicine Treatment Guidelines and the MSA
Speakers:
Robert Sagrillo, JD, LLM
President, Chief Legal Officer
NuQuest
Longwood, FL
Jennifer Shymanski, JD, CMSP
Director of Implementation and Strategy
NuQuest
Longwood, FL
This panel will examine the role that Evidence Based Medicine Treatment Guidelines play in shaping the Medicare Set‐Aside in a claim. By keeping these guidelines in mind while developing defense strategies, the claims adjuster and defense attorney may work to limit the projections in the Medicare Set‐Aside. The panel will also discuss the impact of these guidelines in the CMS-submitted MSA and the non‐submitted Medicare Set‐Aside.
10:00 – 11:00 am
Managing Pharmaceutical Projections in the MSA Through Evidence Based Medicine Treatment Guidelines
Speakers:
Robert Sagrillo, JD, LLM
President, Chief Legal Officer
NuQuest
Longwood, FL
Jennifer Shymanski, JD, CMSP
Director of Implementation and Strategy
NuQuest
Longwood, FL
State workers’ compensation laws often provide limits on the types of drugs that may be used during the life of a workers’ compensation claim. By implementing these limits in the management of the claim, the claims adjuster and defense attorney can prevent excessive future pharmaceutical projections in both the non‐submitted and the submitted Medicare Set‐Aside. Join our speakers for a discussion of the best ways to manage pharmaceutical projections in the Medicare Set‐Aside through Evidence Based Medicine Treatment Guidelines.